Personal tools

UBERON:0002346

From FANTOM5_SSTAR

Jump to: navigation, search

Name:neurectoderm
Namespace:FANTOM
Definition:"Embryonic ectoderm that gives rise to nervous tissue." [Wikipedia:Neuroectoderm]
Xrefs:
links:

AAO:0011074
BILA:0000039
EHDAA2:0001248
EHDAA:1498
EHDAA:255
EMAPA:16073
EV:0100004
FBbt:00001061
FMA:87657
MAT:0000176
MIAA:0000176
ncithesaurus:Neuroectoderm
TAO:0001120
VHOG:0000150
XAO:0000042

ZFA:0001120
Synonyms: "epithelium tubi neuralis; neuroectoderma" RELATED LATIN [Wikipedia:Neuroectoderm]
"neuaral ectoderm" RELATED []
"neural ectoderm" EXACT []
"neuroectoderm" EXACT []
"presumptive central nervous system" RELATED []
Comments:Terminology notes: we prefer neurectoderm to neural ectoderm since placodal ectoderm is not classified here
Alt_id: UBERON:FMA_87657-MIAA_0000176-XAO_0000042-ZFA_0001120
Subset: uberon_slim
vertebrate_core

Ontology association<br>Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:UBERON:0000923(germ layer),UBERON:0004121(ectoderm-derived structure)
develops_from:UBERON:0000924(ectoderm)



Children

is a:FF:10637-108I7 (neuroectodermal tumor cell line:FU-RPNT-1),FF:10663-109C6 (neuroectodermal tumor cell line:FU-RPNT-2),FF:10697-109G4 (peripheral neuroectodermal tumor cell line:KU-SN),FF:10774-110F9 (neuroectodermal tumor cell line:TASK1)
develops from:UBERON:0001775 (ciliary body),UBERON:0003050 (olfactory placode),UBERON:0003075 (neural plate),UBERON:0004128 (optic vesicle),UBERON:0007284 (presumptive neural plate)
part of:UBERON:0002342 (neural crest),UBERON:0003075 (neural plate),UBERON:0006238 (future brain)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Uberon ontology


Human (Homo sapiens)

  • 10637-108I7 (neuroectodermal tumor cell line:FU-RPNT-1)
  • 10663-109C6 (neuroectodermal tumor cell line:FU-RPNT-2)
  • 10697-109G4 (peripheral neuroectodermal tumor cell line:KU-SN)
  • 10774-110F9 (neuroectodermal tumor cell line:TASK1)


Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0002346 (neurectoderm), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
4.32e-103FFCP PHASE2:Hg19::chr5:11588907..11588967,-#_bd062af150aa963ed51e7e9d934ed8efp3@CTNND2
4.32e-103FFCP PHASE1:Hg19::chr5:11588907..11588967,-#_bd062af150aa963ed51e7e9d934ed8efp3@CTNND2
2.11e-102FFCP PHASE2:Hg19::chr11:31839488..31839515,-#_8dc4b39ace8db98571f91e9642041862p3@PAX6
2.11e-102FFCP PHASE1:Hg19::chr11:31839488..31839515,-#_8dc4b39ace8db98571f91e9642041862p3@PAX6
1.77e-98FFCP PHASE2:Hg19::chr17:54230819..54230848,+#_c1c1ede1ef4df0d8ec9eeac91abc8be4p1@ANKFN1
1.77e-98FFCP PHASE1:Hg19::chr17:54230819..54230848,+#_c1c1ede1ef4df0d8ec9eeac91abc8be4p1@ANKFN1
2.49e-97FFCP PHASE2:Hg19::chr4:165305086..165305179,-#_cd57bb4c92e029287be62bb4bed16ba2p2@MARCH1
2.49e-97FFCP PHASE1:Hg19::chr4:165305086..165305179,-#_cd57bb4c92e029287be62bb4bed16ba2p2@MARCH1
2.85e-95FFCP PHASE1:Hg19::chr2:74612644..74612670,+#_1d96d1a8ec231b01f41e5c3fa438eea8p1@ENST00000412957
2.85e-95FFCP PHASE2:Hg19::chr2:74612644..74612670,+#_1d96d1a8ec231b01f41e5c3fa438eea8p1@ENST00000412957
3.65e-95FFCP PHASE2:Hg19::chr5:87439352..87439386,-#_c472a433a31db705ca50e4e0aecce02ap@chr5:87439352..87439386, -
3.65e-95FFCP PHASE1:Hg19::chr5:87439352..87439386,-#_c472a433a31db705ca50e4e0aecce02ap@chr5:87439352..87439386, -
1.65e-94FFCP PHASE1:Hg19::chr5:87980761..87980821,-#_78b99d73b7566a84611a5b6a3d0a194ap4@LINC00461
1.65e-94FFCP PHASE2:Hg19::chr5:87980761..87980821,-#_78b99d73b7566a84611a5b6a3d0a194ap4@LINC00461
1.56e-93FFCP PHASE2:Hg19::chr5:11384884..11384916,-#_8e1d297cf484e5f41dd6410283478271p8@CTNND2
1.56e-93FFCP PHASE1:Hg19::chr5:11384884..11384916,-#_8e1d297cf484e5f41dd6410283478271p8@CTNND2
1.77e-93FFCP PHASE1:Hg19::chr12:106976678..106976708,+#_1e247056b5d86a89ca60fc29f2a74b66p2@RFX4
1.77e-93FFCP PHASE2:Hg19::chr12:106976678..106976708,+#_1e247056b5d86a89ca60fc29f2a74b66p2@RFX4
2.16e-93FFCP PHASE1:Hg19::chr2:50201220..50201261,-#_da56ce4e11f4dbd3bd4dc9ccbe56ab84p3@NRXN1
2.16e-93FFCP PHASE2:Hg19::chr2:50201220..50201261,-#_da56ce4e11f4dbd3bd4dc9ccbe56ab84p3@NRXN1
3.46e-93FFCP PHASE2:Hg19::chr9:19789059..19789070,-#_c5539c3439ea4d11fac2c6d4602ab5fdp2@SLC24A2
3.46e-93FFCP PHASE1:Hg19::chr9:19789059..19789070,-#_c5539c3439ea4d11fac2c6d4602ab5fdp2@SLC24A2
4.22e-93FFCP PHASE1:Hg19::chr18:32398296..32398318,+#_cc3c4012c91c5a58c14b88842203841fp7@DTNA
4.22e-93FFCP PHASE2:Hg19::chr18:32398296..32398318,+#_cc3c4012c91c5a58c14b88842203841fp7@DTNA
6.23e-93FFCP PHASE2:Hg19::chr8:18541544..18541592,-#_376611e6a68c61ba611de00387f92a9cp2@PSD3
6.23e-93FFCP PHASE1:Hg19::chr8:18541544..18541592,-#_376611e6a68c61ba611de00387f92a9cp2@PSD3
1.56e-92FFCP PHASE2:Hg19::chr11:62475005..62475041,-#_e7da1fb647ba04cbe195713c3cc7b9a5p6@BSCL2
1.56e-92FFCP PHASE1:Hg19::chr11:62475005..62475041,-#_e7da1fb647ba04cbe195713c3cc7b9a5p6@BSCL2
2.16e-92FFCP PHASE1:Hg19::chr5:146314142..146314146,-#_2c9d469415df6818e5ddd345a882197ep@chr5:146314142..146314146, -
2.16e-92FFCP PHASE2:Hg19::chr5:146314142..146314146,-#_2c9d469415df6818e5ddd345a882197ep@chr5:146314142..146314146, -
4.94e-92FFCP PHASE1:Hg19::chr12:20848486..20848542,+#_7e08cc427ec23c56f9dc3e1518602a3ep1@SLCO1C1
4.94e-92FFCP PHASE2:Hg19::chr12:20848486..20848542,+#_7e08cc427ec23c56f9dc3e1518602a3ep1@SLCO1C1
9.18e-92FFCP PHASE2:Hg19::chrX:139803820..139803865,+#_89c074be138cf86bbfc34aa4fd195316p@chrX:139803820..139803865, +
9.18e-92FFCP PHASE1:Hg19::chrX:139803820..139803865,+#_89c074be138cf86bbfc34aa4fd195316p@chrX:139803820..139803865, +
1.02e-91FFCP PHASE2:Hg19::chr17:36760961..36760976,-#_40a91a2b19ff1dd240aef9d4d74c8f28p2@SRCIN1
1.02e-91FFCP PHASE1:Hg19::chr17:36760961..36760976,-#_40a91a2b19ff1dd240aef9d4d74c8f28p2@SRCIN1
1.19e-91FFCP PHASE2:Hg19::chr4:46126009..46126045,-#_b62c2782e16c014a9403881933c2ce09p1@GABRG1
1.19e-91FFCP PHASE1:Hg19::chr4:46126009..46126045,-#_b62c2782e16c014a9403881933c2ce09p1@GABRG1
2.32e-91FFCP PHASE1:Hg19::chr19:30016395..30016433,+#_7d6b4417a17eb425a0d916ab2bdafffbp@chr19:30016395..30016433, +
2.32e-91FFCP PHASE2:Hg19::chr19:30016395..30016433,+#_7d6b4417a17eb425a0d916ab2bdafffbp@chr19:30016395..30016433, +
3.27e-91FFCP PHASE1:Hg19::chr5:11386115..11386130,-#_62a95ab462e4e382a1ccc674d92d8cdbp2@CTNND2
3.27e-91FFCP PHASE2:Hg19::chr5:11386115..11386130,-#_62a95ab462e4e382a1ccc674d92d8cdbp2@CTNND2
5.78e-91FFCP PHASE1:Hg19::chr15:46702499..46702523,+#_04914067a754282c3e6a0eae38dcf7fap@chr15:46702499..46702523, +
5.78e-91FFCP PHASE2:Hg19::chr15:46702499..46702523,+#_04914067a754282c3e6a0eae38dcf7fap@chr15:46702499..46702523, +
6.2e-91FFCP PHASE1:Hg19::chr12:106976656..106976672,+#_7d0d999631f1334f0b4bd977a7d1e50cp4@RFX4
6.2e-91FFCP PHASE2:Hg19::chr12:106976656..106976672,+#_7d0d999631f1334f0b4bd977a7d1e50cp4@RFX4
6.65e-91FFCP PHASE1:Hg19::chr1:84630574..84630602,+#_b75f839fcc859b72b9d629eec8c8c392p9@PRKACB
6.65e-91FFCP PHASE2:Hg19::chr1:84630574..84630602,+#_b75f839fcc859b72b9d629eec8c8c392p9@PRKACB
9.73e-91FFCP PHASE2:Hg19::chrX:13835398..13835429,-#_4f20beee53d81507f1e288c053ca23d7p6@GPM6B
9.73e-91FFCP PHASE1:Hg19::chrX:13835398..13835429,-#_4f20beee53d81507f1e288c053ca23d7p6@GPM6B
9.99e-91FFCP PHASE1:Hg19::chr1:84630610..84630621,+#_cc687b30f3da5ea98248b2de63b4d57cp17@PRKACB
9.99e-91FFCP PHASE2:Hg19::chr1:84630610..84630621,+#_cc687b30f3da5ea98248b2de63b4d57cp17@PRKACB
1.35e-90FFCP PHASE2:Hg19::chr6:136848260..136848296,-#_16ecab561d68d6dd49337d21c2a6c42fp4@MAP7
1.35e-90FFCP PHASE1:Hg19::chr6:136848260..136848296,-#_16ecab561d68d6dd49337d21c2a6c42fp4@MAP7
1.57e-90FFCP PHASE1:Hg19::chr16:4850844..4850888,-#_99f65588b38ad6115e340d84aa08c89ep@chr16:4850844..4850888, -
1.57e-90FFCP PHASE2:Hg19::chr16:4850844..4850888,-#_99f65588b38ad6115e340d84aa08c89ep@chr16:4850844..4850888, -
2.14e-90FFCP PHASE2:Hg19::chr10:62149542..62149590,-#_3f2246a6b1dbd14c4746d1ab1fca6e06p1@ANK3
2.14e-90FFCP PHASE1:Hg19::chr10:62149542..62149590,-#_3f2246a6b1dbd14c4746d1ab1fca6e06p1@ANK3
2.39e-90FFCP PHASE1:Hg19::chr9:87283501..87283520,+#_c8b347a5f7836a39f893dab48f809250p17@NTRK2
2.39e-90FFCP PHASE2:Hg19::chr9:87283501..87283520,+#_c8b347a5f7836a39f893dab48f809250p17@NTRK2
2.61e-90FFCP PHASE2:Hg19::chr1:2005182..2005194,+#_38acf2b18b60af807dac980dfe535c2dp8@PRKCZ
2.61e-90FFCP PHASE1:Hg19::chr1:2005182..2005194,+#_38acf2b18b60af807dac980dfe535c2dp8@PRKCZ
4.63e-90FFCP PHASE1:Hg19::chr6:80131670..80131724,+#_8544af35a0fefb192a15b943778ba76fp@chr6:80131670..80131724, +
4.63e-90FFCP PHASE2:Hg19::chr6:80131670..80131724,+#_8544af35a0fefb192a15b943778ba76fp@chr6:80131670..80131724, +
4.84e-90FFCP PHASE2:Hg19::chr12:106976774..106976788,+#_df3ea3fc2216b355676ab100f9ae2f60p1@RFX4
4.84e-90FFCP PHASE1:Hg19::chr12:106976774..106976788,+#_df3ea3fc2216b355676ab100f9ae2f60p1@RFX4
5.68e-90FFCP PHASE2:Hg19::chr13:25746318..25746350,-#_976b4ddb15056d073786de4fb917d83bp3@FAM123A
5.68e-90FFCP PHASE1:Hg19::chr13:25746318..25746350,-#_976b4ddb15056d073786de4fb917d83bp3@FAM123A
7.47e-90FFCP PHASE1:Hg19::chr5:160279207..160279247,-#_fce8ade68f5ab3a23b04ec56ac3afecep1@ATP10B
7.47e-90FFCP PHASE2:Hg19::chr5:160279207..160279247,-#_fce8ade68f5ab3a23b04ec56ac3afecep1@ATP10B
8.65e-90FFCP PHASE1:Hg19::chr4:46126063..46126087,-#_efc8830fb9cc84121323a27221deec76p2@GABRG1
8.65e-90FFCP PHASE2:Hg19::chr4:46126063..46126087,-#_efc8830fb9cc84121323a27221deec76p2@GABRG1
8.97e-90FFCP PHASE1:Hg19::chr16:76311254..76311274,+#_21c7492d5be9069555b921c34bd3f89dp2@CNTNAP4
8.97e-90FFCP PHASE2:Hg19::chr16:76311254..76311274,+#_21c7492d5be9069555b921c34bd3f89dp2@CNTNAP4
2.17e-89FFCP PHASE2:Hg19::chr7:47420733..47420758,-#_3e4fdfaeed64019643743390380a6b27p@chr7:47420733..47420758, -
2.17e-89FFCP PHASE1:Hg19::chr7:47420733..47420758,-#_3e4fdfaeed64019643743390380a6b27p@chr7:47420733..47420758, -
2.55e-89FFCP PHASE1:Hg19::chrX:13835312..13835321,-#_8d139e3539f377ef2ac6ba76c22b5e05p9@GPM6B
2.55e-89FFCP PHASE2:Hg19::chrX:13835312..13835321,-#_8d139e3539f377ef2ac6ba76c22b5e05p9@GPM6B
2.57e-89FFCP PHASE1:Hg19::chr5:112074041..112074101,+#_287882d2e37a57738bb3ad1741d8d485p4@APC
2.57e-89FFCP PHASE2:Hg19::chr5:112074041..112074101,+#_287882d2e37a57738bb3ad1741d8d485p4@APC
2.87e-89FFCP PHASE2:Hg19::chr2:74612614..74612643,+#_1b988fb3548f32e14af0000397805d64p1@ENST00000418990, p1@ENST00000426715, p1@ENST00000427343
2.87e-89FFCP PHASE1:Hg19::chr2:74612614..74612643,+#_1b988fb3548f32e14af0000397805d64p1@ENST00000418990, p1@ENST00000426715, p1@ENST00000427343
7.17e-89FFCP PHASE1:Hg19::chr18:32398400..32398416,+#_e2291f5f0c22d1600291fa7b663e02eap10@DTNA
7.17e-89FFCP PHASE2:Hg19::chr18:32398400..32398416,+#_e2291f5f0c22d1600291fa7b663e02eap10@DTNA
8.04e-89FFCP PHASE1:Hg19::chr17:68101117..68101162,+#_75e12a2cb5a2e2487cd094f9940f29c6p2@KCNJ16
8.04e-89FFCP PHASE2:Hg19::chr17:68101117..68101162,+#_75e12a2cb5a2e2487cd094f9940f29c6p2@KCNJ16
8.72e-89FFCP PHASE1:Hg19::chr18:32398372..32398394,+#_e4906d31ef8775238cc003dd027a4a80p5@DTNA
8.72e-89FFCP PHASE2:Hg19::chr18:32398372..32398394,+#_e4906d31ef8775238cc003dd027a4a80p5@DTNA
9.14e-89FFCP PHASE1:Hg19::chr17:42989121..42989166,-#_04ed10eee94b5349558cd56e7b554f45p7@GFAP
9.14e-89FFCP PHASE2:Hg19::chr17:42989121..42989166,-#_04ed10eee94b5349558cd56e7b554f45p7@GFAP
2.05e-88FFCP PHASE1:Hg19::chr6:56716896..56716928,-#_0ad1530a3a573e756cbf3b231ea01ec1p8@DST
2.05e-88FFCP PHASE2:Hg19::chr6:56716896..56716928,-#_0ad1530a3a573e756cbf3b231ea01ec1p8@DST
2.12e-88FFCP PHASE1:Hg19::chr5:11384929..11384947,-#_682c44bd4c3ef61699d2e042cca0133bp15@CTNND2
2.12e-88FFCP PHASE2:Hg19::chr5:11384929..11384947,-#_682c44bd4c3ef61699d2e042cca0133bp15@CTNND2
2.37e-88FFCP PHASE2:Hg19::chr10:25940658..25940700,+#_aa2b9aa533272dcb43be94f704f2838dp1@ENST00000450270
2.37e-88FFCP PHASE1:Hg19::chr10:25940658..25940700,+#_aa2b9aa533272dcb43be94f704f2838dp1@ENST00000450270
2.7e-88FFCP PHASE1:Hg19::chr17:7558857..7558903,+#_ba693a8adbf4405b75e2863ea0d14156p@chr17:7558857..7558903, +
2.7e-88FFCP PHASE2:Hg19::chr17:7558857..7558903,+#_ba693a8adbf4405b75e2863ea0d14156p@chr17:7558857..7558903, +
2.76e-88FFCP PHASE2:Hg19::chr15:30261066..30261096,-#_5f45967e8cbb0b0853110215131eae33p12@TJP1
2.76e-88FFCP PHASE1:Hg19::chr15:30261066..30261096,-#_5f45967e8cbb0b0853110215131eae33p12@TJP1